IndexResearch and Development in Process
| Name | ResearchAndDevelopmentInProcess |
|---|---|
| Namespace | http://fasb.org/us-gaap/2020-01-31 |
| Prefix | us-gaap |
| Data type | xbrli:monetaryItemType |
| Period type | duration |
| Substitution Group | xbrli:item |
| Balance | debit |
| Nillable | True |
| Abstract | False |
Labels
| Text | Lang | Role | Container role |
|---|---|---|---|
| Research and Development in Process | en-US | http://www.xbrl.org/2003/role/label | http://www.xbrl.org/2003/role/link |
| The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. | en-US | http://www.xbrl.org/2003/role/documentation | http://www.xbrl.org/2003/role/link |
References
| Name | Value | Role |
|---|---|---|
| SourceName | Cash Flows | http://fasb.org/srt/role/changeNote/changeNote |
| TaxonomyVersion | 2018 | http://fasb.org/srt/role/changeNote/changeNote |
| ChangeDate | 2017-08 | http://fasb.org/srt/role/changeNote/changeNote |
| ModifiedReferences | true | http://fasb.org/srt/role/changeNote/changeNote |